NDLI: Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis

Content Provider	Springer Nature : BioMed Central
Author	Chang, Katherine Svabek, Catherine Vazquez-Guillamet, Cristina Sato, Bryan Rasche, David Wilson, Strother Robbins, Paul Ulbrandt, Nancy Suzich, JoAnn Green, Jonathan Patera, Andriani C Blair, Wade Krishnan, Subramaniam Hotchkiss, Richard
Abstract	Introduction A major pathophysiologic mechanism in sepsis is impaired host immunity which results in failure to eradicate invading pathogens and increased susceptibility to secondary infections. Although many immunosuppressive mechanisms exist, increased expression of the inhibitory receptor programmed cell death 1 (PD-1) and its ligand (PD-L1) are thought to play key roles. The newly recognized phenomenon of T cell exhaustion is mediated in part by PD-1 effects on T cells. This study tested the ability of anti-PD-1 and anti-PD-L1 antibodies to prevent apoptosis and improve lymphocyte function in septic patients. Methods Blood was obtained from 43 septic and 15 non-septic critically-ill patients. Effects of anti-PD-1, anti-PD-L1, or isotype-control antibody on lymphocyte apoptosis and interferon gamma (IFN-γ) and interleukin-2 (IL-2) production were quantitated by flow cytometry. Results Lymphocytes from septic patients produced decreased IFN-γ and IL-2 and had increased CD8 T cell expression of PD-1 and decreased PD-L1 expression compared to non-septic patients (P<0.05). Monocytes from septic patients had increased PD-L1 and decreased HLA-DR expression compared to non-septic patients (P<0.01). CD8 T cell expression of PD-1 increased over time in ICU as PD-L1, IFN-γ, and IL2 decreased. In addition, donors with the highest CD8 PD-1 expression together with the lowest CD8 PD-L1 expression also had lower levels of HLA-DR expression in monocytes, and an increased rate of secondary infections, suggestive of a more immune exhausted phenotype. Treatment of cells from septic patients with anti-PD-1 or anti-PD-L1 antibody decreased apoptosis and increased IFN-γ and IL-2 production in septic patients; (P<0.01). The percentage of CD4 T cells that were PD-1 positive correlated with the degree of cellular apoptosis (P<0.01). Conclusions In vitro blockade of the PD-1:PD-L1 pathway decreases apoptosis and improves immune cell function in septic patients. The current results together with multiple positive studies of anti-PD-1 and anti-PD-L1 in animal models of bacterial and fungal infections and the relative safety profile of anti-PD-1/anti-PD-L1 in human oncology trials to date strongly support the initiation of clinical trials testing these antibodies in sepsis, a disorder with a high mortality.
Related Links	https://ccforum.biomedcentral.com/counter/pdf/10.1186/cc13176.pdf
Ending Page	15
Page Count	15
Starting Page	1
File Format	HTM / HTML
ISSN	13648535
DOI	10.1186/cc13176
Journal	Critical Care
Issue Number	1
Volume Number	18
Language	English
Publisher	BioMed Central
Publisher Date	2014-01-04
Access Restriction	Open
Subject Keyword	Intensive Critical Care Medicine Emergency Medicine Septic Patient Myeloid Derive Suppressor Cell Absolute Lymphocyte Count Isotype Control Antibody Lymphocyte Apoptosis
Content Type	Text
Resource Type	Article
Subject	Critical Care and Intensive Care Medicine
Journal Impact Factor	8.8/2023
5-Year Journal Impact Factor	10.4/2023

Sl.	Authority	Responsibilities	Communication Details
1	Ministry of Education (GoI), Department of Higher Education	Sanctioning Authority	https://www.education.gov.in/ict-initiatives
2	Indian Institute of Technology Kharagpur	Host Institute of the Project: The host institute of the project is responsible for providing infrastructure support and hosting the project	https://www.iitkgp.ac.in
3	National Digital Library of India Office, Indian Institute of Technology Kharagpur	The administrative and infrastructural headquarters of the project	Dr. B. Sutradhar bsutra@ndl.gov.in
4	Project PI / Joint PI	Principal Investigator and Joint Principal Investigators of the project	Dr. B. Sutradhar bsutra@ndl.gov.in Prof. Saswat Chakrabarti will be added soon
5	Website/Portal (Helpdesk)	Queries regarding NDLI and its services	support@ndl.gov.in
6	Contents and Copyright Issues	Queries related to content curation and copyright issues	content@ndl.gov.in
7	National Digital Library of India Club (NDLI Club)	Queries related to NDLI Club formation, support, user awareness program, seminar/symposium, collaboration, social media, promotion, and outreach	clubsupport@ndl.gov.in
8	Digital Preservation Centre (DPC)	Assistance with digitizing and archiving copyright-free printed books	dpc@ndl.gov.in
9	IDR Setup or Support	Queries related to establishment and support of Institutional Digital Repository (IDR) and IDR workshops	idr@ndl.gov.in

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis

Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis

A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis

CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study

Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study

Association between apoptosis and mortality in severe septic patients

Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients

Cell death in sepsis: a matter of how, when, and where

Death to sepsis: targeting apoptosis pathways in sepsis

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis

Similar Documents

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis

Soluble programmed cell death protein-1 and programmed cell death ligand-1 in sepsis

A prospective analysis of lymphocyte phenotype and function over the course of acute sepsis

CD4+ lymphocyte adenosine triphosphate determination in sepsis: a cohort study

Lymphocyte subset expression and serum concentrations of PD-1/PD-L1 in sepsis - pilot study

Association between apoptosis and mortality in severe septic patients

Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients

Cell death in sepsis: a matter of how, when, and where

Death to sepsis: targeting apoptosis pathways in sepsis

Targeting the programmed cell death 1: programmed cell death ligand 1 pathway reverses T cell exhaustion in patients with sepsis